“Cardiovascular Risk With Gender‑Affirming Hormone Therapy”. Canadian Diabetes & Endocrinology Today 4, no. 2 (August 26, 2026): 34–40. Accessed August 27, 2026. https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-2-Druce.